WellGen
North Brunswick · Founded 1997
About WellGen
WellGen, Inc. is a biotechnology company at the crossroads of foods and pharmaceuticals. Using the science of nutrigenomics, the company has developed Alignomxâ„¢, a proprietary bioinformatics model that uses gene expression data to determine optimal therapeutic areas for WellGen's pipeline of proprietary natural products. Through its in-house expertise in nutrigenomics and natural product chemistry, WellGen is developing proprietary medical foods and has additionally identified several opportunities in the functional food and beverage and dietary supplement markets. WellGen is a portfolio company of Amphion Innovations (LSE: AMP).
Company Facts
- Founded: 1997
- Legal name: WELLGEN, INC.
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $16.5M
- Funding stage: Late Stage Venture
- Last round: Series C (Oct 2007)
- Website: wellgen.com
- Phone: +1 7325653896
Social Profiles
Canonical: https://fsome.com/organization/wellgen-8397177 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.